FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24618211000001105: Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80060501000001114 Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80060601000001113 Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has specific active ingredient Recombinant human bone morphogenetic protein 7 true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Is a Eptotermin alfa 3.3mg powder for implantation suspension vials 1 vial true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has AMP Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has specific active ingredient Eptotermin alfa false Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Has dispensed dose form Implantation suspension true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start